Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04750330
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2021-01-26
Brief Title:
Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection
Sponsor:
Organization:
Maastricht University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Saliva samples will be collected for analysis of
Mitochondrial DNA variants
Nuclear SNPs candidate approach
In case blood samples are present already they can be used instead of saliva However patients will never be asked to have extra blood samples to be collected if those samples arent present If no samples are present theyll be asked to collect saliva
Enrollment Count:
394
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 72789 |
Who Masked List: